WPI 845 (Glipizide extended release 10 mg)

Pill imprint WPI 845 has been identified as Glipizide extended release 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 845

Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845
Glipizide extended release
Imprint:
WPI 845
Strength:
10 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0845
Inactive Ingredients:
acetyltributyl citrate
hydroxyethyl cellulose (2000 mpa.s at 1%)
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
polyethylene glycol
shellac
isopropyl alcohol
ferrosoferric oxide
butyl alcohol
propylene glycol
ammonia
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0112 Amerisource Health Services
00228-2900 Actavis (acquired Watson & Warner Chilcott)
54569-5548 A S Medication Solutions LLC (repackager)
54868-4988 Physicians Total Care Inc (repackager)
58016-0691 Southwood Pharmaceuticals Inc (repackager)
55887-0179 Diversified Healthcare Services Inc (repackager)
55289-0301 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)